COLLECTIONS
WORKFLOWS
Viatar CTC Solutions
Recent Finacing
Series B
Recent Raise
Undisclosed
Viatar CTC Solutions develops the Viatar Oncopheresis System, a label-free cross-flow filtration device that removes circulating tumor cells from whole blood and enables liquid-biopsy collection and regulatory/clinical programs.
Highlights
Focus Areas
Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
Financials
$60M
Valuation as of 03/01/2016
1
Funding round